Vitiligo responds to topical aryl hydrocarbon receptor agonist tapinarof (WBI-1001)
oleh: Lisa Liu, BS, Qianli Yang, MD, Ming-wan Su, PhD, Youwen Zhou, MD, PhD
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2023-09-01 |
Deskripsi
Subjek
autoimmune disorder; pigmentation; vitiligo